After 48 h, biofilms were washed once with 1 PBS followed by treatment with different concentrations of 0, 5, 10, 25, and 50 M H 2 O 2 (prepared by diluting an aliquot of 30% (v/v) H 2 O 2 in 1 PBS) for 24 h, at 37C and shaking at 150 rpm
Protective effect of propionyl-L-carnitine against PAF-induced rat paw oedema
Astellas Pharma Inc., Tokyo, Japan), and butorphanol (5 mg/kg body weight
The law in relation to peptides is different to other performance-enhancing drugs
Clinical development documentation
As of a January 2026 legal analysis, BPC-157 remained listed in Category 2, and the compound cannot legally be compounded under sections 503A or 503B of the Food, Drug and Cosmetic Act